alopecia

(redirected from Male pattern)
Also found in: Dictionary, Thesaurus, Medical.
Related to Male pattern: male pattern baldness

alopecia

(ăl'əpē`shēə): see baldnessbaldness,
thinning or loss of hair as a result of illness, functional disorder, or hereditary disposition; also known as alopecia. Male pattern baldness, a genetic trait, is the most common cause of baldness among white males.
..... Click the link for more information.
.

Alopecia

 

(baldness), thinning or complete absence of hair in an isolated area or on the entire surface of the skin.

Alopecia is usually localized on the scalp and face; less frequently, it is localized in the armpits, the pubic region, or elsewhere. Congenital, premature, senile, and other forms of the disease exist. Symptomatic alopecia—the result of acute infections, nervous diseases, poisoning, endocrine disorders, fungal diseases, or secondary syphilis—is characterized by the temporary focal or diffuse loss of hair in any region of the body; the skin remains unaltered at the morbid site. Alopecia areata, a special type of baldness, is manifested by the sudden appearance of hairless foci that are round or oval and well defined. With the merging of these foci, complete baldness can occur; the skin is unchanged and subjective sensations are absent. Angioneurosis and endocrine disorders are the principal causes of alopecia areata.

Congenital alopecia is rarely encountered; the manifestation of a developmental disorder, it is usually noticed at birth or in the first months of life. Premature alopecia is observed most often in men 20 to 25 years of age. The condition is characterized by the gradual, progressive loss of hair from the scalp. The skin in such cases becomes thin, and its texture, silky. In women affected with premature alopecia, only a thinning of hair occurs. In both men and women, senile alopecia progresses in a manner similar to premature alopecia but sets in at a later age (55–60 years). Senile alopecia is a result of normal physiological aging.

Treatment of alopecia involves the administering of vitamins A, B1, and B6, of hormones, and furocoumarin preparations—peucedanin, Beroksan, Ammifurin—in combination with ultraviolet irradiation. Topical measures include physiotherapy, massage, and rubbing with tinctures of cayenne pepper.

REFERENCES

Zalkind, E. S. Bolezni volos. [Leningrad] 1959.
Mnogotomnoe rukovodstvopo dermatovenerologii, vol. 3. Moscow, 1964.

I. IA. SHAKHTMEISTER

alopecia

[‚a·lə′pē·shə]
(medicine)
Loss of hair; baldness.

alopecia

loss of hair, esp on the head; baldness
References in periodicals archive ?
The role of platelet plasma growth factors in male pattern baldness surgery.
Most common in men, male pattern baldness also affects some women and is usually more noticeable after a woman has been through the menopause.
"What we've found is promising, though we haven't yet shown it is effective for male pattern baldness," said Dr.
Biopharmaceutical company KYTHERA Biopharmaceuticals (NasdaqGS:KYTH) disclosed on Tuesday that it has submitted an Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) for KYTH-105 (setipiprant) for treatment of androgenetic alopecia (AGA), or male pattern hair loss.
Today, the classification is named Hamilton-Norwood classification and used more frequently in male pattern AGA scoring.
In the meantime, men with male pattern baldness may need to be followed more closely for prostate cancer, a Cleveland Clinic expert says.
3 ( ANI ): Gravity may help explain the apparently paradoxical effects of testosterone in male pattern baldness, or androgenic alopecia (AGA), a new research has revealed.
ISLAMABAD -- Male pattern baldness is linked to an increased risk of coronary heart disease, but only if it's on the top/crown of the head, a new study has revealed.
The most common cause is hereditary male pattern baldness, caused by oversensitivity of hair follicles to the male hormone testosterone.
Researchers from the University of Tokyo's Department of Diabetes and Metabolic Diseases analysed six studies on male pattern baldness and coronary heart disease conducted between 1993 and 2008 with nearly 40,000 participants in the United States and Europe.
This patented red light technology device is now FDA cleared for the treatment of androgenetic alopecia (male pattern hair loss).
Finasteride is indicated for the treatment of benign prostatic hyperplasia and male pattern baldness.